Skip to main content

Table 3 Univariate and multivariate analyses of the association between the overall survival of 137 patients with colorectal cancer

From: Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer

Variables Univariate analysis Multivariate analysis
HR (95% CI) P-value HR (95% CI) P-value
Age 1.12 (0.94-1.31) 0.576   
Gender 0.99 (0.87-1.14) 0.834   
Tumor size 1.41 (1.13-1.68) 0.033 1.04 (0.89-1.18) 0.473
Depth of wall invasion 1.33 (0.98-1.70) 0.065   
Lymph node metastasis 1.47 (1.08-1.85) 0.014 1.24 (0.96-1.47) 0.085
Distant metastasis 1.54 (1.22-1.92) 0.007 1.38 (1.12-1.63) 0.006*
TNM stage 1.67 (1.39-1.94) <0.001 1.48 (1.15-1.77) 0.004*
Differentiation 1.41 (1.18-1.65) 0.009 1.26 (1.02-1.51) 0.041*
Adjuvant chemotherapy 1.37 (1.05-1.74) 0.023 1.14 (0.91-1.39) 0.093
PSF3 expression 1.59 (1.26-1.95) <0.001 1.35 (1.10-1.64) 0.002*
  1. CI confidence interval, HR hazard ratio, PSF3 partner of Sld five 3.
  2. *Significant P-value in multivariate analysis.